Answers are grounded in this paper and cite their sources.
The US FDA recognizes that there are many challenges to ensuring that medical devices are used responsibly and safely in the pediatric population. Education plays a key role, and manufacturers and healthcare providers must be informed of medical device issues unique to the pediatric population. Healthcare workers and device manufacturers must recognize that adverse events may differ between the adult and pediatric population and among pediatric subpopulations. Risk mitigation may also differ, and heightened awareness will reduce the potential for adverse events and promote the safe use of medical devices in children.
No takes yet. Share an insight, caveat, or question.
Samuels‐Reid et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: